Electroacupuncture Anesthesia for Nasal Sinus Surgery and Mammaplasty

Xijing Hospital137 enrolled

Overview

The purpose of this study is to verify the intraoperative analgesia of electroacupuncture in patients undergoing selective nasal sinus surgery and mammaplasty.

Acupuncture therapy has been proved helpful in the patients suffering from various pain problems. And it is reported to be able to reduce the intraoperative anesthetic requirement. However, so far there is few evidence from randomized controlled studies to confirm the assistant anesthetic effect of acupuncture. Electroacupuncture (EA) is a modern non-invasive technique of traditional acupuncture. Compared to traditional acupuncture, EA is more practicable, more easily to be accepted by patients and operated by physicians. Nasal sinus surgery and mammaplasty, especially breast augmentation, mostly belong to the scope of day surgeries, which demand a rapid, smooth recovery from anesthesia with minimum adverse side effects (e.g.: pain, PONV, etc).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

137

Conditions

Therapeutic (Nonsurgical) and Rehabilitative Anesthesiology Devices Associated With Adverse Incidents

Interventions

non-electroacupuncturePROCEDURE

The same procedure as electroacupuncture except stimulation

ElectroacupuncturePROCEDURE

Electrodes are applied to bilateral "Hegu(L14)" acupoints at the time of 1h before operation, and connected to Hwato Electronic Acupuncture Treatment Instrument (Model No. SDZ-V, Suzhou Medical Appliances Co., Ltd., Suzhou, China). The acupoints are stimulated at an intensity of 3\~6 mA and a frequency of 2/30 Hz for 30 min. The highest intensity will be chosen at which the patient can tolerate.

Eligibility

Sex: ALLMin age: 29 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * selective nasal sinus surgery * selective mammaplasty * patients who accept the follow-up and sign the informed consent * ASA 1\~2 Exclusion Criteria: * emergent surgery * pregnant or breast-feeding women * coagulopathy * history of gastrointestinal ulcer * liver or renal dysfunction * enrollment in other clinical trials at the same time not reaching the primary endpoint and probably interference the present trial

Locations (1)

Xijing Hospital

Xi'an, Shaanxi, China

Outcomes

Primary Outcomes

the mean infusion rate of intraoperative remifentanil and propofol

To investigate the operative time and total volume of remifentanil and propofol used during operation, and then calculate the mean infusion rate. To assess whether intraoperative requirements for anesthetic drugs could be reduced by EA pretreatment.

Time frame: during operation

Secondary Outcomes

Visual analogue scale

To assess whether EA pretreatment could help in alleviating acute post-operative pain.

Time frame: post-operative 4h, 8h, 24h and 48h

Extubation time

To investigate the time from the end of propofol and remifentanil infusion to extubation. To assess whether EA pretreatment could shorten the extubation time.

Time frame: postoperation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.